GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | -100.0% | 19 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 19 | -52.5% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 40 | -16.7% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 48 | +20.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | -84.6% | 40 | -87.3% | 0.00% | -100.0% |
Q4 2018 | $13,000 | -99.8% | 315 | +129.9% | 0.00% | 0.0% |
Q2 2018 | $6,193,000 | +19253.1% | 137 | -79.0% | 0.00% | -66.7% |
Q1 2018 | $32,000 | +700.0% | 653 | +573.2% | 0.00% | – |
Q4 2017 | $4,000 | +100.0% | 97 | +59.0% | 0.00% | – |
Q3 2017 | $2,000 | -66.7% | 61 | -70.2% | 0.00% | -100.0% |
Q2 2017 | $6,000 | +20.0% | 205 | +40.4% | 0.00% | – |
Q1 2017 | $5,000 | -44.4% | 146 | -77.0% | 0.00% | -100.0% |
Q4 2016 | $9,000 | – | 636 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 177,414 | $14,103,000 | 11.50% |
Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |